Objectives. To characterize 18 F-fluorodeoxyglucose ( 18 F-FDG) uptake on whole-body PET/CT in PMR, and identify its precise anatomic correlate using MRI.
Introduction
PMR is an inflammatory condition predominantly characterized by subacute-onset shoulder and hip pain and stiffness in patients 550 years of age. Some controversy has existed as to whether PMR represents a distinct disease entity due to its close relationship with both GCA and lateonset RA, however, imaging modalities such as PET have recently uncovered its distinctive pathology [13] .
Blockmans et al.
[4] first reported the ability of PET to detect articular inflammation in PMR, finding abnormal 18 F-fluorodeoxyglucose ( 18 F-FDG) uptake in the shoulders and hips in 94 and 89% of patients, respectively. They additionally described a novel finding involving the processi spinosi of the vertebrae, which has since been localized to the interspinous bursa on MRI [5, 6] .
The pairing of whole-body PET with low-dose CT has facilitated further study of the anatomic distribution of PMR. 18 F-FDG uptake in the trochanteric region and adjacent to the ischial tuberosities has been attributed to trochanteric and ischiogluteal bursitis, respectively [7] . A high frequency of knee involvement due to capsulitis has similarly been reported [8] . However, the low resolution of whole-body PET/CT images remains a limitation to precise identification of anatomic correlates of abnormal 18 F-FDG uptake. Peripheral joint involvement is appreciated clinically in almost half of PMR patients [9] . Distinguishing this group from late-onset RA at presentation is especially difficult. However, it is increasingly apparent from imaging studies that the prevailing pathology in PMR is extra-articular rather than intra-articular [10] . Unlike RA, a predilection for tendinous and bursal structures combined with capsular joint involvement is typically observed.
In this study we sought to further characterize the pattern of 18 F-FDG uptake on whole-body PET/CT in untreated patients with newly diagnosed PMR. Utilizing dedicated hand views, additional emphasis was also placed upon the distribution and frequency of peripheral joint involvement. MRI was subsequently performed in representative patients before fusion technology was employed to precisely identify anatomic correlates of abnormal 18 F-FDG uptake.
Methods

Patients
Patients with newly diagnosed PMR according to the 2012 EULAR/ACR classification criteria (utilizing the clinical scoring algorithm) [9] were prospectively recruited from primary care, community and hospital rheumatology practices. Participants who had received prior prednisolone treatment and those with symptoms suggestive of GCA (headache, scalp tenderness, jaw claudication or visual disturbance) were excluded, as were patients with a history of cancer within the past 5 years, neuromuscular disease, active infection, other inflammatory conditions and chronic pain syndromes. The study was approved by the Austin Health Human Research Ethics Committee prior to commencement and registered with the Australian New Zealand Clinical Trials Registry (trial identification ACTRN1261400696695).
Clinical and laboratory variables
Following appropriate written consent, demographic and clinical data were collected. Participants also completed the HAQ disability index (HAQ-DI). A standard physical examination was carried out with specific focus on the presence of peripheral synovitis. Baseline laboratory testing comprised full blood count, CRP, ESR, creatinine kinase, thyroid function testing, RF and ACPAs. Bilateral wrist and hand X-rays were performed to assess for erosive change. B-mode and power Doppler US was undertaken at both wrists by a rheumatologist experienced in US (C.E.O.) using a LOGIQ e machine (GE Healthcare, Chicago, IL, USA) with linear 513 MHz transducer.
Whole-body PET/CT
A whole body 18 F-FDG PET/CT scan (Gemini-TF64 or Ingenuity-TF128 PET/CT system; Phillips, Cleveland, OH, USA) from skull vertex to toes (including dedicated hand views) was performed within 7 days of the screening visit and prior to the commencement of prednisolone treatment. Following a minimum 6 h fast, participants received a weight-based i.v. injection of 18 F-FDG. The emission study and low-dose CT was acquired after a 1 h rest period, with CT attenuation correction performed on all whole-body and dedicated hand images prior to independent qualitative and semiquantitative analysis of abnormal 18 F-FDG uptake by two experienced nuclear medicine physicians (A.P. and S.T.L.). Any significant differences in results were resolved by consensus. Qualitative analysis involved visual evaluation of 18 F-FDG uptake using the following scoring system: 0, no uptake; 1, lower than normal liver uptake; 2, similar to normal liver uptake; 3, higher than normal liver uptake. A score 51 was considered a positive result. For semiquantitative analysis, a region of interest was drawn around each site and the maximum standardized uptake value (SUV max ) calculated. The following sites were specifically assessed: two shoulder joints, two hip joints, two trochanteric regions, regions adjacent to the two ischial tuberosities, most FDG-avid interspinous bursa, two knee joints, two wrist joints and two hands.
MRI correlation and fusion of PET/CT with MRI
To precisely identify anatomic correlates of abnormal 18 F-FDG uptake, MRI was performed in three representative patients at the pelvis, knee and wrist and hand using a 1.5 T magnet (Siemens Avanto, Erlangen, Germany) with a Siemens i-PAT compatible six-element design phased array body matrix, Siemens 12 channel transmit/receive configuration knee coil and Invivo 8 channel wrist coil, respectively. For imaging of the pelvis, non-contrast T1-weighted fast spin-echo (FSE) sequences in the axial plane, proton density-weighted FSE sequences in the axial, sagittal and coronal planes with fat saturation in the coronal plane and T2-weighted FSE sequences with fat saturation in the axial plane centred on the ischial tuberosities were obtained.
For imaging of the knee, proton density-weighted FSE and T2-weighted FSE sequences with fat saturation in the coronal plane, proton density-weighted FSE with fat saturation in the sagittal plane and proton density-weighted FSE and T2-weighted FSE images with fat saturation in the axial plane were obtained.
For imaging of the wrist and hand, the following sequences were performed before i.v. injection: proton density-weighted FSE in the axial, coronal and sagittal planes with fat saturation in the coronal plane; T2-weighted FSE in the axial plane with fat suppression and 3D T2*-weighted GRE in the coronal plane. Following i.v. injection of 10 ml of gadolinium-based contrast agent (Dotarem, gadoterate meglumine, Guerbet USA, Princeton, NJ, USA), T1-weighted FSE fat suppression images in the axial and coronal planes were obtained.
Interpretation of MRIs was performed by two experienced musculoskeletal radiologists (L.Y., R.Z.). Medview fusion software (Ann Arbor, MI, USA) was utilized to align and superimpose PET and MRI datasets and to anatomically correlate sites of abnormal 18 F-FDG uptake adjacent to the ischial tuberosities and of posteromedial knee structures.
Statistical analysis Results for continuous variables are reported as mean (S.D.) or median [interquartile range (IQR)]. Categorical variables are represented as proportions (percentages).
All statistical analyses were undertaken using Stata 13.0 (StataCorp, College Station, TX, USA).
Results
Patient demographics, clinical and laboratory features
Twenty-two patients met the inclusion criteria for a diagnosis of PMR [mean clinical algorithm score 5.1 (S.D. 0.7)]. Their demographic data are summarized in Table 1 . The mean age at diagnosis was 68.3 years (S.D. 6.3). Thirteen patients (59.1%) were male and all participants were Caucasian.
Consistent with the 2012 EULAR/ACR classification criteria, all patients possessed bilateral shoulder pain, with 18/22 (81.8%) also reporting concomitant hip pain. Fourteen participants (63.6%) indicated involvement of their knees, while 12 (54.5%) reported wrist and/or hand symptoms. The median duration of early morning stiffness was 120 min (IQR 60120). On clinical examination, synovitis at the wrist and/or hand was detected in nine patients (40.9%) and six (27.3%) exhibited swelling and/or tenderness of the knee.
All participants were negative for ACPAs. Three patients returned a low positive RF result [14 IU/ml in two participants and 17 IU/ml in the third (n < 14 IU/ml)]. A single patient was found to possess a subtle marginal erosion of the right fourth metacarpal head on bilateral wrist and hand X-rays. Using US, greyscale synovitis was detected at the wrist in eight patients (36.4%), five (22.7%) of whom had associated power Doppler signal.
Using the PMR activity score, disease activity was judged to be high [ F-FDG uptake in a peri-articular distribution was observed at the shoulder and hip joints in 22 (100%) and 19 patients (86.4%), respectively (Table 2) . FDG avidity was present in all cases in the trochanteric regions.
Adjacent to the ischial tuberosities ( Fig. 1A and B) represented another site of frequent 18 F-FDG uptake (95.4%) and recorded the highest value for mean reference score ). In the majority of these, focal areas of intense FDG avidity in a posteromedial distribution were appreciated ( Fig. 1C and D) . A high frequency of wrist and/or hand involvement was also detected (66.7%). At the hand, a volar distribution of abnormal 18 F-FDG uptake was typically observed ( Fig. 1E and F) . Vascular 18 F-FDG uptake in the large vessels consistent with a diagnosis of GCA (qualitative score 52) was not present in any participant.
MRI correlation and fusion of PET/CT with MRI
MRI of the pelvis in a patient with characteristic, intense 18 F-FDG uptake adjacent to the ischial tuberosities revealed bilateral and symmetric high T2 signal surrounding the proximal hamstring tendon origins of the semimembranosus and the conjoint tendon of the semitendinosus and biceps femoris (Fig. 2D) . These changes were confined to the paratenon, with only minimally increased signal noted for the tendons themselves. There was similarly no abnormality observed at the musculotendinous junctions, nor any evidence of bone oedema adjacent to the tendon entheses.
At the knee, MRI in a representative patient with posteromedial 18 F-FDG uptake on whole-body PET/CT revealed peritendonitis of the semimembranosus and to a lesser extent the gracilis tendons at their distal insertion (Fig. 3D) . No bone oedema was appreciated at the medial tibial plateau. The distal semitendinosus tendon was normal in this instance. MRI of the wrist and hand in a patient with a volar distribution of 18 F-FDG uptake revealed extensive synovial thickening and enhancement within the carpal tunnel with extension to involve the common flexor tendon sheaths of the digits, in keeping with tenosynovitis (Fig. 4B) . Mild extensor tenosynovitis was also appreciated, along with moderate mid-carpal joint synovitis (Fig. 4D) . PET/MRI fusion at the pelvis subsequently confirmed peritendonitis of the proximal hamstring tendon origins as the anatomical correlate of abnormal 18 F-FDG uptake adjacent to the ischial tuberosities on whole-body PET/CT (Fig. 2E) , while abnormal 18 F-FDG uptake of posteromedial knee structures correlated with peritendonitis of the distal semimembranosus tendon (Fig. 3E) . The same technique could not be utilized at the wrist and hand due to discrepancies in positioning between the two imaging modalities at this site. 
Discussion
On whole-body PET/CT, 22 untreated patients with newly diagnosed PMR exhibited a distinctive pattern of abnormal 18 F-FDG uptake around the shoulder and hip joints, in the trochanteric regions and interspinous bursae and adjacent to the ischial tuberosities. In addition, a high frequency of knee and wrist and/or hand involvement was appreciated. Using PET/MRI fusion, hamstring peritendonitis was identified as the anatomical correlate of 18 F-FDG uptake adjacent to the ischial tuberosities and of posteromedial knee structures. Uptake adjacent to the ischial tuberosities has been previously reported in whole-body PET/CT studies of PMR patients at rates ranging from 52 to 94% [13, 7, 1114] . Our results reinforce a high incidence of involvement at this site, with abnormal uptake present in all but one patient. Furthermore, these focal areas of FDG avidity within the pelvis recorded the highest value for mean reference score compared with normal liver and highest mean SUV max . Intense 18 F-FDG uptake adjacent to the ischial tuberosities should therefore be considered an imaging hallmark of PMR on whole-body PET/CT.
The ischiogluteal bursa is situated over the ischial tuberosity, hence abnormal 18 F-FDG uptake in this region on whole-body PET/CT has been previously attributed to ischiogluteal bursitis [15] . Cantini et al. [16] studied hip inflammatory changes on US and MRI in 20 consecutive PMR patients but found no significant difference in the incidence of ischiogluteal bursitis compared with a group of controls (20% vs 25%). Conversely, a recent retrospective study of whole-body PET/CT proposed that praepubic 18 F-FDG uptake in PMR represented a correlate of pectineus and adductor longus enthesitis and tenosynovitis [13] . The superior ramus of the ischium is also the tendinous origin for several hamstring muscles [17] . Given that our MRI correlation at the pelvis revealed high T2 signal confined to the paratenon of semimembranosus and the conjoint tendon of semitendinosus and biceps femoris without corresponding abnormality of the ischiogluteal bursa, we conclude that hamstring peritendonitis (as opposed to ischiogluteal bursitis) represents the anatomical correlate of 18 F-FDG uptake adjacent to the ischial tuberosities in PMR. Cimmino et al.
[8] first reported a high frequency of knee involvement in PMR on whole-body PET/CT. In their study, 24/25 patients (96%) exhibited 18 F-FDG uptake in a distribution that highlighted the contour of the fibrous joint capsule. Focal areas of FDG avidity were also appreciated in 13 participants (52%), predominantly in a posteromedial distribution. We have similarly detected 18 F-FDG uptake at the knee capsule in 10/21 patients (47.6%) and of posteromedial knee structures in 13/21 patients (61.9%). Based on results from the MRI correlation undertaken at the knee, this pattern of posteromedial knee involvement on whole-body PET/CT is also attributable to peritendonitis of the semimembranosus tendon at its insertion on the medial condyle of the tibia. Pelvic girdle symptoms are said to occur in 60% of PMR cases, although a higher incidence of hip pain was recorded in this study (81.8%). Patients with PMR commonly report gluteal and posterior thigh pain and stiffness that are aggravated by prolonged sitting. It has been previously acknowledged that hip joint synovitis provides an inadequate explanation for this distribution of symptoms, given such pathology is typically felt in the groin [16] . Our documentation of hamstring peritendonitis on PET/ MRI fusion would therefore appear to provide a better explanation for this symptomatology. To our knowledge, this is the first study to evaluate the distribution and frequency of peripheral joint involvement on whole-body PET/CT in PMR. Dedicated hand views were utilized for this purpose, detecting abnormal 18 F-FDG uptake at the wrist and/or hand in 14 patients (66.7%). Twelve participants (54.5%) reported wrist and/ or hand pain at study enrolment, with nine of these individuals (75.0%) possessing corresponding findings on whole-body PET/CT. Upon further analysis of this subgroup, reasonable concordance [7/8 patients (87.5%)] was seen between the presence of abnormal 18 F-FDG uptake at the wrist and/or hand and greyscale synovitis on US. None of the participants with wrist and/or hand involvement on whole-body PET/CT possessed erosive changes on plain X-ray. There were similar frequencies of abnormal 18 F-FDG uptake observed at the shoulder (100% vs 100%), hip (92.9% vs 71.4%), trochanteric regions (100% vs 100%) and adjacent to the ischial tuberosities (100% vs 85.7%) between patients with wrist and/ or hand involvement and those without.
Values for the mean reference score and SUV max at the wrist/hand were lower than most other sites throughout the body, with only six (28.6%) and three (14.3%) patients exhibiting 18 F-FDG uptake 52 at the wrist joint and volar hand, respectively. While this may infer an overestimate of abnormal findings at the wrist and/or hand in this study, significant FDG avidity was consistently appreciated at the knee. It therefore seems clear that both clinical and subclinical peripheral joint involvement occurs frequently in PMR, firmly contradicting the notion that PMR is a condition limited to the shoulder and hip girdle but also clouding its relationship with late-onset RA. In the 2012 EULAR/ ACR classification criteria, peripheral synovitis, presence of RF and/or ACPAs and hip pain/limited range of motion best discriminated RA from PMR, yet distal swelling, tenosynovitis or arthritis was appreciated in 39% of the PMR cohort studied and 51% reported other joint pain [9] . This, together with our findings, demonstrates the difficulty of using peripheral joint involvement as a means of distinguishing PMR from late-onset RA. Further studies of abnormal 18 F-FDG uptake in the peripheries on whole-body PET/CT and the longitudinal outcomes of PMR patients with this pattern of involvement are needed. Correlation of volar 18 F-FDG uptake at the hand with flexor tenosynovitis on MRI is also noteworthy. A previous study of 13 consecutive patients with PMR (who were not selected on the basis of peripheral arthritis) and 13 controls who underwent MRI of the wrist and hand demonstrated an increased occurrence of tenosynovitis but not synovitis [18] . Extensor tendon tenosynovitis was seen in 9/26 PMR hands (34.6%) compared with 1/26 controls (3.8%) (P = 0.002), with flexor tenosynovitis appreciated in 12/26 PMR hands (46.1%) compared with 4/26 (15.4%) controls (P = 0.03). Since seven patients (33.3%) in our study exhibited a volar distribution of abnormal 18 F-FDG uptake at the hand, the incidence of flexor tenosynovitis appears to be similar in this cohort.
Together, these results highlight a predilection for tendon involvement in PMR and further substantiate the hypothesis that intra-articular inflammation is not the prevailing pathology in this condition. McGonagle et al. [19] initially proposed that a capsular and extracapsular pattern of joint involvement predominated following their MRI study comparing the shoulders of PMR patients with those affected by RA. More recently, this distribution of inflammation on whole-body MRI has been associated with complete patient-reported glucocorticoid response [20] . Recognition of a distinct imaging phenotype on both MRI and whole-body PET/CT has significant implications for ongoing research in the PMR field. Utilization of these modalities in future studies will be vital to ensure population homogeneity beyond that which can be achieved with conventional classification criteria.
There are several limitations to our study. First, small numbers may have resulted in an overrepresentation of participants with peripheral joint involvement by chance alone. Furthermore, the 2012 EULAR/ACR classification criteria have been utilized to determine a diagnosis of PMR in this instance. While these criteria have been established as highly sensitive, their ability to discriminate PMR from other inflammatory conditions with shoulder pain has been questioned [21, 22] . Misclassification therefore remains an inherent difficulty when researching PMR, with 8% of patients according to the 2012 criteria having a change in diagnosis after long-term follow-up [9, 22] .
Three patients returned low positive RF results that were deemed clinically insignificant. All three of these were notably ACPA negative. Only one of these individuals [RF 14 IU/l (normal <14 IU/ml)] reported wrist and/or hand pain, however, synovitis could not be appreciated on physical examination. Importantly, the exclusion of these three patients from the statistical analyses does not significantly alter the study results. In particular, knee and wrist and/or hand involvement is still appreciated in the remaining 13/18 participants (72.2%) and 11/18 participants (61.1%), respectively.
Finally, neither healthy controls nor controls with other rheumatic conditions (e.g. late-onset RA, OA) were enrolled as comparator groups in this study. In the former case, this was due to ethical concerns regarding the radiation exposure associated with whole-body PET/CT. It is well established, however, that 18 F-FDG uptake in a distribution like that observed in our patients does not routinely occur in the absence of underlying pathology. Furthermore, a recent retrospective study comparing PET/CT findings in patients with PMR and cancer controls without rheumatologic disease demonstrated highly statistically significant differences in 18 F-FDG uptake at multiple sites including the shoulders, interspinous bursae and adjacent to the ischial tuberosities (P < 0.00001 for FDG uptake score) [11] . Whether the involvement of posteromedial knee structures that we have documented is highly specific to PMR remains unknown and will, in the https://academic.oup.com/rheumatology future, need to be compared with patterns of peripheral joint 18 F-FDG uptake in other rheumatic conditions.
Conclusion
Intense 18 F-FDG uptake adjacent to the ischial tuberosities and of posteromedial knee structures is common among untreated patients with PMR on whole-body PET/CT. Using fusion technology, we have provided the first documentation of a hamstring peritendonitis as the anatomical correlate of abnormalities detected at both of these sites. In doing so, an alternate explanation for the aetiology of the gluteal and posterior thigh pain that typically characterizes PMR is proposed. A high frequency of wrist and/or hand involvement has also been observed for the first time in this study by performing dedicated views on whole-body PET/CT. Abnormal 18 F-FDG uptake in a volar distribution at the hand was found to correlate with flexor tenosynovitis on MRI. These findings add to our growing understanding of the imaging phenotype of PMR and further highlight its distinctive pathology, including a predilection for extra-articular structures distal to the shoulder and pelvic girdles. Further studies are now needed to determine the relationship between peripheral abnormalities detected on whole-body PET/CT and the longitudinal outcomes in this subset of PMR patients.
